PSP Research »

Monte Rosa Therapeutics shares owned by PSP Research

Quarter-by-quarter ownership of Monte Rosa Therapeutics (GLUE) shares owned by PSP Research from 13F filings

Historical chart of PSP Research investment in Monte Rosa Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Monte Rosa Therapeutics held by PSP Research consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Monte Rosa Therapeutics by PSP Research

Quarter filed Position value Share count Share price at filing
2026-03-31 $461k 28k 16.45

More positions owned by PSP Research

Ishares Tr 0-3 Mnth Treasry (SGOV)
Spdr Series Trust State Street Spd (XBI)
Sera Prognostics Class A Com (SERA)
Definium Therapeutics Com Shs (DFTX)
Tyra Biosciences (TYRA)
Ascendis Pharma A/s Sponsored Adr (ASND)
Pharvaris N V (PHVS)
Cytokinetics Com New (CYTK)
Royalty Pharma Shs Class A (RPRX)
Kymera Therapeutics (KYMR)
Halozyme Therapeutics (HALO)
Exelixis (EXEL)
Disc Medicine (IRON)
Ionis Pharmaceuticals (IONS)
Agios Pharmaceuticals (AGIO)

View all positions for PSP Research

Top funds holding Monte Rosa Therapeutics

NEA Management Company
TCG Crossover Management
Versant Venture Management
Baker Bros. Advisors
BlackRock
BVF
Suvretta Capital Management
Vanguard Group
State Street Corporation
Aisling Capital Management
American Century Companies
FMR
Geode Capital Management
MPM Oncology Impact Management
Silverarc Capital Management

View all funds holding Monte Rosa Therapeutics